If (I know, big if) Provenge is stat sig at the interim look, DNDN will finish 2008 MUCH higher than where it appears it will start the year. If we can deviate to some of the small medical device companies we mention here, than I would add CAMH and RPBIF as additional choices for possible large turnarounds.